Conversion of crestor to lipitor

Size: px
Start display at page:

Download "Conversion of crestor to lipitor"

Transcription

1 Conversion of crestor to lipitor Apr 25, Atorvastatin (Lipitor ): 10 mg, Fluvastatin (Lescol ): 80 mg, Rosuvastatin. Nov 16, In a head-to-head test of two popular cholesterol-lowering statin drugs Lipitor and Crestor both medications worked equally well. Lipitor. To discuss conversion to the Preferred Drug or to request authorization for a Non- Preferred drug, please. PREFERRED. Atorvastatin. Rosuvastatin. 10 mg. STATIN CONVERSION CHART. DIRTIT. % LDL. Reduction. <24% % % % % % %. Simvastatin Atorvastatin Rosuvastatin. Dec 25, Atorvastatin (40 mg) and rosuvastatin (10 mg) are both FDA approved. Angiotensin converting enzyme inhibitor, 12 (80%), 11 (73%), (ZOCOR*). LESCOL. LIPITOR. generic for coverage. Dose Conversion Table for Statins:. Aug 5, Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-hdl-c: Results from the VOYAGER. Therapeutic Interchange From Rosuvastatin to Atorvastatin in a conversion program. Atorvastatin1 (Lipitor ). Rosuvastatin (Crestor ). 5 mg. 1 formulary drug; all statins other than pravastatin will be converted to atorvastatin (see TIP section). Componente activo cozaar. Cozaar 50 mg bijsluiter. Cozaar bradycardia. Cozaar blood pressure parameters. Cozaar ahumada. Cozaar plm. Acheter cozaar. Cozaar scheda tecnica. Pravachol official prescribing pharmacology and more. Women have four hot spots. Did you know this? I didn t. Up until a week ago, I thought there were only three: The clitoris, the G-Spot, and the U-Spot. Lipitor official prescribing pharmacology and more. Quick over the counter viagra alternative :.

2 Welchol (Colesevelam) is used to lower levels of the "bad" cholesterol, or low-density lipoprotein (LDL), when combined with proper diet and exercise. In the subsequent years, the business developed favorably and Lonza was the first fine chemical company entering in a strategic partnership with SKF. In a similar way, Fine Organics, UK became the supplier of the thioethyl-n -methyl-2- nitro-1,1-ethenediamine moiety of ranitidine, the second H2 receptor antagonist, marketed as Zantac by Glaxo. Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications XMSN 3000 RDS (5 SPEED). Information and articles on creatine kinase and how creatine kinase can effect your body. Apr 25, Atorvastatin (Lipitor ): 10 mg, Fluvastatin (Lescol ): 80 mg, Rosuvastatin. Aug 5, Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-hdl-c: Results from the VOYAGER. STATIN CONVERSION CHART. DIRTIT. % LDL. Reduction. <24% % % % % % %. Simvastatin Atorvastatin Rosuvastatin. Dec 25, Atorvastatin (40 mg) and rosuvastatin (10 mg) are both FDA approved. Angiotensin converting enzyme inhibitor, 12 (80%), 11 (73%), Atorvastatin1 (Lipitor ). Rosuvastatin (Crestor ). 5 mg. 1 formulary drug; all statins other than pravastatin will be converted to atorvastatin (see TIP section). (ZOCOR*). LESCOL. LIPITOR. CRESTOR. VYTORIN %. 20 MG. WILL NOT require patient to try a generic for coverage. Dose Conversion Table for Statins:. Nov 16, In a head-to-head test of two popular cholesterol-lowering statin drugs Lipitor and Crestor both medications worked equally well. Lipitor. Therapeutic Interchange From Rosuvastatin to Atorvastatin in a conversion program. To discuss conversion to the Preferred Drug or to request authorization for a Non- Preferred drug, please. PREFERRED. Atorvastatin. Rosuvastatin. 10 mg. Welchol (Colesevelam) is used to lower levels of the "bad" cholesterol, or low-density lipoprotein (LDL), when combined with proper diet and

3 exercise. Information and articles on creatine kinase and how creatine kinase can effect your body XMSN 3000 RDS (5 SPEED). Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. In the subsequent years, the business developed favorably and Lonza was the first fine chemical company entering in a strategic partnership with SKF. In a similar way, Fine Organics, UK became the supplier of the thioethyl-n -methyl-2- nitro-1,1-ethenediamine moiety of ranitidine, the second H2 receptor antagonist, marketed as Zantac by Glaxo. Quick over the counter viagra alternative :. Lipitor official prescribing pharmacology and more. Pravachol official prescribing information for healthcare professionals. Includes: Componente activo cozaar. Cozaar 50 mg bijsluiter. Cozaar bradycardia. Cozaar blood pressure parameters. Cozaar ahumada. Cozaar plm. Acheter cozaar. Cozaar scheda tecnica. Women have four hot spots. Did you know this? I didn t. Up until a week ago, I thought there were only three: The clitoris, the G-Spot, and the U-Spot. Nov 16, In a head-tohead test of two popular cholesterollowering statin drugs Lipitor and Crestor both medications worked equally well. Lipitor. Atorvastatin1 (Lipitor ). Rosuvastatin (Crestor ). 5 mg. 1 formulary drug; all statins other than pravastatin will be converted to atorvastatin (see TIP section). Therapeutic Interchange From Rosuvastatin to Atorvastatin in a conversion program. Aug 5, Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-hdl-c: Results from the VOYAGER. (ZOCOR*). LESCOL. LIPITOR. generic for coverage. Dose Conversion Table for Statins:. Apr 25, Atorvastatin (Lipitor ): 10 mg, Fluvastatin (Lescol ): 80 mg, Rosuvastatin. STATIN CONVERSION CHART. DIRTIT. % LDL. Reduction. <24% %. 31-

4 39% % % % %. Simvastatin Atorvastatin Rosuvastatin. Dec 25, Atorvastatin (40 mg) and rosuvastatin (10 mg) are both FDA approved. Angiotensin converting enzyme inhibitor, 12 (80%), 11 (73%), To discuss conversion to the Preferred Drug or to request authorization for a Non- Preferred drug, please. PREFERRED. Atorvastatin. Rosuvastatin. 10 mg. Welchol (Colesevelam) is used to lower levels of the "bad" cholesterol, or low-density lipoprotein (LDL), when combined with proper diet and exercise. Information and articles on creatine kinase and how creatine kinase can effect your body. Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Componente activo cozaar. Cozaar 50 mg bijsluiter. Cozaar bradycardia. Cozaar blood pressure parameters. Cozaar ahumada. Cozaar plm. Acheter cozaar. Cozaar scheda tecnica. In the subsequent years, the business developed favorably and Lonza was the first fine chemical company entering in a strategic partnership with SKF. In a similar way, Fine Organics, UK became the supplier of the thioethyl-n -methyl-2-nitro-1,1- ethenediamine moiety of ranitidine, the second H2 receptor antagonist, marketed as Zantac by Glaxo. Women have four hot spots. Did you know this? I didn t. Up until a week ago, I thought there were only three: The clitoris, the G-Spot, and the U-Spot. Lipitor official prescribing information for healthcare professionals. Includes: Pravachol official prescribing pharmacology and more XMSN 3000 RDS (5 SPEED). Quick over the counter viagra alternative :. Aug 5, Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-hdl-c: Results from the VOYAGER. Nov 16, In a headto-head test of two popular cholesterollowering statin drugs Lipitor and Crestor both medications worked equally well. Lipitor. STATIN CONVERSION CHART. DIRTIT. % LDL. Reduction. <24% % % % % % %. Simvastatin Atorvastatin Rosuvastatin. Atorvastatin1 (Lipitor ).

5 Rosuvastatin (Crestor ). 5 mg. 1 formulary drug; all statins other than pravastatin will be converted to atorvastatin (see TIP section). Dec 25, Atorvastatin (40 mg) and rosuvastatin (10 mg) are both FDA approved. Angiotensin converting enzyme inhibitor, 12 (80%), 11 (73%), (ZOCOR*). LESCOL. LIPITOR. generic for coverage. Dose Conversion Table for Statins:. Pravachol official prescribing pharmacology and more. Componente activo cozaar. Cozaar 50 mg bijsluiter. Cozaar bradycardia. Cozaar blood pressure parameters. Cozaar ahumada. Cozaar plm. Acheter cozaar. Cozaar scheda tecnica. Welchol (Colesevelam) is used to lower levels of the "bad" cholesterol, or low-density lipoprotein (LDL), when combined with proper diet and exercise. In the subsequent years, the business developed favorably and Lonza was the first fine chemical company entering in a strategic partnership with SKF. In a similar way, Fine Organics, UK became the supplier of the thioethyl-n -methyl-2- nitro-1,1-ethenediamine moiety of ranitidine, the second H2 receptor antagonist, marketed as Zantac by Glaxo. Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications XMSN 3000 RDS (5 SPEED). Women have four hot spots. Did you know this? I didn t. Up until a week ago, I thought there were only three: The clitoris, the G-Spot, and the U-Spot. Lipitor official prescribing information for healthcare professionals. Includes: Quick over the counter viagra alternative :. Information and articles on creatine kinase and how creatine kinase can effect your body. Therapeutic Interchange From Rosuvastatin to Atorvastatin in a conversion program. To discuss conversion to the Preferred Drug or to request authorization for a Non- Preferred drug, please. PREFERRED. Atorvastatin. Rosuvastatin. 10 mg. (ZOCOR*). LESCOL. LIPITOR.

6 generic for coverage. Dose Conversion Table for Statins:. Aug 5, Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-hdl-c: Results from the VOYAGER. Nov 16, In a headto-head test of two popular cholesterollowering statin drugs Lipitor and Crestor both medications worked equally well. Lipitor. Atorvastatin1 (Lipitor ). Rosuvastatin (Crestor ). 5 mg. 1 formulary drug; all statins other than pravastatin will be converted to atorvastatin (see TIP section). Apr 25, Atorvastatin (Lipitor ): 10 mg, Fluvastatin (Lescol ): 80 mg, Rosuvastatin. Pravachol official prescribing pharmacology and more. Quick over the counter viagra alternative :. Women have four hot spots. Did you know this? I didn t. Up until a week ago, I thought there were only three: The clitoris, the G-Spot, and the U- Spot INTERNATIONAL 7400 ( ) Body LABRIE EXPERT "T" 2000 (29 YARD) Engine IH MAXXFORCE 9 (310 HP) Transmission ALLISON XMSN 3000 RDS (5 SPEED). Learn about Lipitor (Atorvastatin Calcium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Lipitor official prescribing information for healthcare professionals. Includes: Componente activo cozaar. Cozaar 50 mg bijsluiter. Cozaar bradycardia. Cozaar blood pressure parameters. Cozaar ahumada. Cozaar plm. Acheter cozaar. Cozaar scheda tecnica. Information and articles on creatine kinase and how creatine kinase can effect your body. In the subsequent years, the business developed favorably and Lonza was the first fine chemical company entering in a strategic partnership with SKF. In a similar way, Fine Organics, UK became the supplier of the thioethyl-n -methyl-2-nitro-1,1- ethenediamine moiety of ranitidine, the second H2 receptor antagonist, marketed as Zantac by Glaxo.

Pravastatin conversion to atorvastatin

Pravastatin conversion to atorvastatin P ford residence southampton, ny Pravastatin conversion to atorvastatin Pravastatin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology

More information

Simvastatin 40 mg equivalent

Simvastatin 40 mg equivalent Simvastatin 40 mg equivalent medications equivalent to Simvastatin is available on the Drugs.com website. Simvastatin (Zocor ): 10 mg : Equivalent Dosages - 3: Atorvastatin (Lipitor. 40 mg : Equivalent

More information

It is the policy of health plans affiliated with PA Health & Wellness that Vytorin is medically necessary when the following criteria are met:

It is the policy of health plans affiliated with PA Health & Wellness that Vytorin is medically necessary when the following criteria are met: Clinical Policy: Ezetimibe and Simvastatin (Vytorin) Reference Number: PA.CP.PMN.77 Effective Date: 02.01.17 Last Review Date: 07.18 Revision Log Description Ezetimibe/simvastatin (Vytorin ) contains ezetimibe,

More information

Zoloft package insert pdf

Zoloft package insert pdf Zoloft package insert pdf The Borg System is 100 % Zoloft package insert pdf It is also approved to treat Obsessive Compulsive Disorder (OCD) in TEENren and adolescents aged 6-17 years. Product names referenced

More information

Atorvastatin and upper arm pain

Atorvastatin and upper arm pain P ford residence southampton, ny Atorvastatin and upper arm pain Caduet (amlodipine and atorvastatin ) is used to treat high blood pressure or angina in patients with high cholesterol. Includes Caduet

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Caduet) Reference Number: CP.CPA.237 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

Crestor and thyroid problems

Crestor and thyroid problems Recently it has been observed that many people on statins have been referred for special radioiodine studies because they have been found to have low to no thyroid stimulating hormone (TSH) in their blood

More information

Clinical Policy: Ezetimibe (Zetia) Reference Number: CP.PMN.78 Effective Date: Last Review Date: 02.19

Clinical Policy: Ezetimibe (Zetia) Reference Number: CP.PMN.78 Effective Date: Last Review Date: 02.19 Clinical Policy: (Zetia) Reference Number: CP.PMN.78 Effective Date: 02.01.17 Last Review Date: 02.19 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.08 Subject: Repatha Page: 1 of 8 Last Review Date: December 2, 2016 Repatha Description Repatha (evolocumab)

More information

Cholesterol. Medicines To Help You

Cholesterol. Medicines To Help You Medicines To Help You Cholesterol Use this guide to help you talk to your doctor, pharmacist, or nurse about your cholesterol medicines. The guide lists all of the FDA-approved products now available to

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.16.08 Subject: Repatha Page: 1 of 8 Last Review Date: September 18, 2015 Repatha Description Repatha

More information

Clinical Policy: Pitavastatin (Livalo), Ezetimibe/Simvastatin (Vytorin 10/10 mg) Reference Number: CP.CPA.62 Effective Date:

Clinical Policy: Pitavastatin (Livalo), Ezetimibe/Simvastatin (Vytorin 10/10 mg) Reference Number: CP.CPA.62 Effective Date: Clinical Policy: Pitavastatin (Livalo), Ezetimibe/Simvastatin (Vytorin 10/10 mg) Reference Number: CP.CPA.62 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.HNMC.05 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important

More information

STATIN UTILIZATION MANAGEMENT CRITERIA

STATIN UTILIZATION MANAGEMENT CRITERIA STATIN UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: HMG Co-A Reductase Inhibitors & Combinations Agents which require prior review: Advicor (niacin extended-release/lovastatin) Crestor (rosuvastatin)(5mg,10mg,

More information

Doctor discussion guide:

Doctor discussion guide: Bring this printout to your next doctor s appointment. It will help you and your doctor work together to set goals for treatment, evaluate the success of your treatment, and reduce your risk of side effects.

More information

High ( 50%) Restrictions mg 20-40mg PA; TS ⱡ 15 ⱡ

High ( 50%) Restrictions mg 20-40mg PA; TS ⱡ 15 ⱡ MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Cholesterol P&T DATE: 5/9/2017 THERAPEUTIC CLASS: Cardiovascular REVIEW HISTORY: 5/16, 5/15, 2/14, 5/12, LOB AFFECTED: Medi-Cal

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

Pravastatin 40mg convert to lipitor

Pravastatin 40mg convert to lipitor Pravastatin 40mg convert to lipitor 05/28/2017 Samantha brown fakes 05/28/2017 Olive garden employee schedules 05/30/2017 -Losertown weight loss calculator -Social skills bingo game printable 05/31/2017

More information

PATIENT INFORMATION. Medicine To Treat: C ardiac Diseases. Lipid-Lowering Medicines. Statins Fibrates Fat Binding Agents Nicotinic Acid Group

PATIENT INFORMATION. Medicine To Treat: C ardiac Diseases. Lipid-Lowering Medicines. Statins Fibrates Fat Binding Agents Nicotinic Acid Group PATIENT INFORMATION Medicine To Treat: C ardiac Diseases Lipid-Lowering Medicines Statins Fibrates Fat Binding Agents Nicotinic Acid Group ABOUT YOUR MEDICINE Your doctor has just prescribed for you: Medicine

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Vytorin) Reference Number: CP.PMN.77 Effective Date: 02.01.17 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

Doctor discussion guide:

Doctor discussion guide: Doctor discussion guide: MAnaging Cholesterol Bring this printout to your next doctor s appointment. It will help you and your doctor work together to set goals for treatment, evaluate the success of your

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Praluent. Praluent (alirocumab) Description

Praluent. Praluent (alirocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.06 Subject: Praluent Page: 1 of 10 Last Review Date: September 20, 2018 Praluent Description Praluent

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Statin Therapy Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Statin Therapy Prime Therapeutics will review Prior Authorization requests. Prior Authorization

More information

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Convert rosuvastatin to atorvastatin

Convert rosuvastatin to atorvastatin Convert atorvastatin 11/01/2017 Is there any sulfur in sucralfate 11/03/2017 Hacked papa games unblocked 11/05/2017 -Gabapentin abuse snorting -Lowes permethrin spray 11/07/2017 Women castrating men topix

More information

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 Promoting high quality, cost effective drug therapy throughout the Military Health System UF Decisions, May 07 Class FY05 rank, total $

More information

Diseases & Conditions

Diseases & Conditions http://my.clevelandclinic.org Diseases & Conditions About Cholesterol-Lowering Drugs Some people have a genetic predisposition to high blood cholesterol levels. These people may need drug therapy in addition

More information

Diflucan and grapefruit

Diflucan and grapefruit Diflucan and grapefruit The Borg System is 100 % Diflucan and grapefruit Feb 26, 2015. Fluconazole (Diflucan) is a medication used to treat fungal infections like thrush in the mouth and throat and yeast

More information

Your cholesterol levels. Questions or concerns

Your cholesterol levels. Questions or concerns Because you have high cholesterol you should: Know your cholesterol levels Take the medicine to lower cholesterol that your doctor has told you to take Follow your doctor s treatment plan Keep your appointments

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.08 Subject: Repatha Page: 1 of 9 Last Review Date: September 15, 2017 Repatha Description Repatha

More information

Repatha. Repatha (evolocumab) Description

Repatha. Repatha (evolocumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.08 Subject: Repatha Page: 1 of 9 Last Review Date: November 30, 2018 Repatha Description Repatha (evolocumab)

More information

Pharmacy Costs: Can I Make a Difference?

Pharmacy Costs: Can I Make a Difference? Pharmacy Costs: Can I Make a Difference? Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately,

More information

Lipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention)

Lipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention) Lipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention) Policy Statement: October 2010 This policy defines the decision made by NHS Wirral following an evidence review

More information

Joshua Shepherd PA-C, MMS, MT (ASCP)

Joshua Shepherd PA-C, MMS, MT (ASCP) Joshua Shepherd PA-C, MMS, MT (ASCP) None What is Cholesterol? Why cholesterol is it important? Review the National Cholesterol Education Programs guidelines (NCEP-ATPIII) Discuss New guidelines from the

More information

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor Page 1 of 5 PHA-GEN-002-2004 CHOLESTEROL REDUCING MEDICATIONS Five Main Categories 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor Statins Also called HMG-CoA reductase inhibitors

More information

Atorvastatin 10 mg cholesterol

Atorvastatin 10 mg cholesterol P ford residence southampton, ny Atorvastatin 10 mg cholesterol Atorvastatin is a cholesterol - lowering medication that blocks the production of cholesterol.. Initial dose: 10 mg to 80 mg orally once

More information

Pravastatin conversion to atorvastatin

Pravastatin conversion to atorvastatin Pravastatin atorvastatin 10/28/2017 The wichita horrorcrime scene photos 10/28/2017 Hydrocodone 7.5 325 street value 10/30/2017 -How do you switch from lyrica to gabapentin -1995 colman fleetwood stoney

More information

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Competency for CDE Exam 3.1.A Oral Medications for Type 2 Diabetes

More information

High ( 50%) Restrictions mg 20-40mg Simvastatin (Zocor) 10mg 20-40mg $1.66 Pravastatin (Pravachol) mg $6.

High ( 50%) Restrictions mg 20-40mg Simvastatin (Zocor) 10mg 20-40mg $1.66 Pravastatin (Pravachol) mg $6. MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Cholesterol P&T DATE: 5/8/2018 THERAPEUTIC CLASS: Cardiovascular REVIEW HISTORY: 5/17, 5/16, 5/15, 2/14, LOB AFFECTED: Medi-Cal

More information

Medications for Treating Stroke

Medications for Treating Stroke Medications for Treating Stroke Subject Expert Sonny Kupniewski, PharmD, BCPS Swedish Medical Center Englewood, CO 2 Objectives Medications used to prevent stroke Prevention of strokes in patients with

More information

Uniform Formulary Decisions 9 January 2014

Uniform Formulary Decisions 9 January 2014 Beneficiary Advisory Panel Handout Uniform Formulary Decisions 9 January 2014 Purpose: The purpose of this handout is to provide the BAP members with a reference document for the clinical effective presentation

More information

Clinical Policy: Mipomersen (Kynamro) Reference Number: ERX.SPA.171 Effective Date:

Clinical Policy: Mipomersen (Kynamro) Reference Number: ERX.SPA.171 Effective Date: Clinical Policy: (Kynamro) Reference Number: ERX.SPA.171 Effective Date: 01.11.17 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these

More information

Understanding Your Patient Care Opportunity Report (PCOR)

Understanding Your Patient Care Opportunity Report (PCOR) Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient

More information

Conversion from atorvastatin to pravastatin

Conversion from atorvastatin to pravastatin Conversion from pravastatin 04/29/2018 Clever team names for work 04/30/2018 Clomid and implantation bleeding 05/01/2018 -Icd 10 code for radiculopathy lower extremity -Icd 10 for wound vac placement 05/02/2018

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. Ezetimibe-simvastatin 10-80 mg oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Investor Presentation

Investor Presentation Investor Presentation May 1, 2018 Albert Friesen Chair, President & CEO James Kinley CFO Forward Looking Statement This presentation is for informational purposes only and should not be considered as an

More information

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be

More information

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................

More information

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action

More information

Achieving Lipid Goals: 2008 Update. Laura Hansen, Pharm.D. Associate Professor, University of Colorado School of Pharmacy

Achieving Lipid Goals: 2008 Update. Laura Hansen, Pharm.D. Associate Professor, University of Colorado School of Pharmacy Achieving Lipid Goals: 2008 Update Laura Hansen, Pharm.D. Associate Professor, University of Colorado School of Pharmacy Discuss relationship between lipid values and coronary events Evaluate clinical

More information

ANCHOR Study Results Overview

ANCHOR Study Results Overview TM ANCHOR Study Results Overview April 18, 2010 Nasdaq: AMRN www.amarincorp.com 1 Forward Looking Statement This presentation contains forward looking statements, including those relating to the Company

More information

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date:

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: Clinical Policy: (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Information in these slides is used with permission from St. Mary s Cardiac Rehab

Information in these slides is used with permission from St. Mary s Cardiac Rehab Information in these slides is used with permission from St. Mary s Cardiac Rehab Prescription Pointers Heart Medications Questions!! 2-4% of patients who visit ER s have experienced a medication misadventure

More information

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you

More information

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins)

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins) Drug Class Review on HMG-CoA Reductase Inhibitors () Final Report June 2004 Mark Helfand, MD, MPH Susan Carson, MPH Cathy Kelley, PharmD Oregon Evidence-based Practice Center Oregon Health & Science University

More information

Clinical Policy: Evolocumab (Repatha) Reference Number: CP.CPA.269 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Evolocumab (Repatha) Reference Number: CP.CPA.269 Effective Date: Last Review Date: Line of Business: Commercial Clinical Policy: (Repatha) Reference Number: CP.CPA.269 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important

More information

Purpose: To establish a guideline in order to reduce ASCVD risk based the four identified statin benefit groups

Purpose: To establish a guideline in order to reduce ASCVD risk based the four identified statin benefit groups Title: Algorithm Based on AHA-13 Report on Lipids Date Created: 11/30/2015 Date Modified: N/A Date Approved by Board of Directors: 12/08/2015 Clinical Guideline # CGC-CG-12 Purpose: To establish a guideline

More information

Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin

Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin Final Report Update 5 November 2009 This report reviews information about the comparative

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION ROSUVASTATIN-5 ROSUVASTATIN-10 ROSUVASTATIN-20 ROSUVASTATIN-40 Rosuvastatin Calcium Tablets This leaflet is part of a oduct Monograph published when ROSUVASTATIN was approved

More information

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa PHARMACY POLICY & PROCEDURES Policy Number: 3.26 Subject: Purpose: Policy: Formulary Management through Establishing Guidelines, Policies or Therapeutic

More information

Pharmaceutical Help to Control Cholesterol

Pharmaceutical Help to Control Cholesterol Pharmaceutical Help to Control Cholesterol Catherine E. Cooke, PharmD, BCPS, PAHM President, PosiHealth, Inc. Clinical Associate Professor, Univ. of Maryland This program has been brought to you by PharmCon

More information

Cardiovascular Drugs and Therapies HMG CoA a REDUCTASE INHIBITORS (available in Canada)

Cardiovascular Drugs and Therapies HMG CoA a REDUCTASE INHIBITORS (available in Canada) Trade Name Dosage Forms 10 mg, 20 mg, 40 mg, 80 mg tablets Dosing Range 10-80 mg once daily 2 Dosing Based on Desired LDL Reduction 1,2,3 HMG CoA a REDUCTASE INHIBITORS (available in Canada) LIPITOR, generics

More information

CLINICAL OUTCOME Vs SURROGATE MARKER

CLINICAL OUTCOME Vs SURROGATE MARKER CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical

More information

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins)

Drug Class Review on HMG-CoA Reductase Inhibitors (Statins) Drug Class Review on HMG-CoA Reductase Inhibitors (Statins) August 2006 Original Report Date: April 2002 Update 1 Report Date: July 2003 Update 2 Report Date: June 2004 Update 3 Report Date: September

More information

B. Patient has not reached the percentage reduction goal with statin therapy

B. Patient has not reached the percentage reduction goal with statin therapy Managing Cardiovascular Risk: The Importance of Lowering LDL Cholesterol and Reaching Treatment Goals for LDL Cholesterol The Role of the Pharmacist Learning Objectives 1. Review the role of lipid levels

More information

Issue date: January Review date: November Statins for the prevention of cardiovascular events. Technology Appraisal 94

Issue date: January Review date: November Statins for the prevention of cardiovascular events. Technology Appraisal 94 Issue date: January 2006 Review date: November 2008 Statins for the prevention of cardiovascular events Technology Appraisal 94 Technology Appraisal 94 Statins for the prevention of cardiovascular events

More information

1.* Dosage. A. Adults

1.* Dosage. A. Adults 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors [Developed, November 1994; Revised, October 1996; September 1997; September 1998; October 1999; November 1999; August 2000; September

More information

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date:

Clinical Policy: Lomitapide (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: Clinical Policy: (Juxtapid) Reference Number: ERX.SPA.170 Effective Date: 01.11.17 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Clinical Policy: Alirocumab (Praluent) Reference Number: CP.CPA.268 Effective Date: Last Review Date: 11.17

Clinical Policy: Alirocumab (Praluent) Reference Number: CP.CPA.268 Effective Date: Last Review Date: 11.17 Clinical Policy: (Praluent) Reference Number: CP.CPA.268 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for

More information

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now?

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now? Disclosures No relationships (not even to an employer) No off-label uses Cholesterol Lowering Guidelines: What now?, FACP 1 2 65-year-old white woman Total cholesterol 175mg/dL HDL 54 mg/dl LDL 96 mg/dl

More information

Is there a link between niacin and stroke?

Is there a link between niacin and stroke? CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Is there a link between niacin and stroke? 7 July 2011 A large American-Canadian study called Aim-High was halted 18 months ahead of schedule.

More information

Parker & Waichman, LLP Attorneys at Law CRESTOR Information Guide

Parker & Waichman, LLP Attorneys at Law CRESTOR Information Guide Parker & Waichman, LLP Attorneys at Law CRESTOR Information Guide The Case Against CRESTOR: Kidney Problems & Rhabdomyolysis Crestor has been linked to serious side effects including: kidney damage, kidney

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Kynamro) Reference Number: CP.PHAR.284 Effective Date: 10.16 Last Review Date: 02.19 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

Pharmacy Drug Class Review

Pharmacy Drug Class Review Pharmacy Drug Class Review January 22, 2014 Authored By: Christina Manciocchi, Pharm.D. BCACP Disclaimer: Specific agents may have variations Edited By: Richard J. Kraft, Pharm.D.BCPS NEW CHOLESTEROL GUIDELINES

More information

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32

More information

Lipid Management Step Therapy Criteria with Medical Diagnoses Option*

Lipid Management Step Therapy Criteria with Medical Diagnoses Option* Lipid Management Step Therapy Criteria with Medical Diagnoses Option* * Medical diagnoses are required for implementation of this option. Program may be implemented with the following options: Option One

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr CADUET (amlodipine besylate and atorvastatin calcium tablets) This leaflet is Part III of a three-part "Product Monograph" published when CADUET was approved for sale

More information

Step One Foods Definitive Guide to Cholesterol and Statins

Step One Foods Definitive Guide to Cholesterol and Statins STEPONEFOODS.COM Step One Foods Definitive Guide to Cholesterol and Statins About the Author Dr. Klodas is a cardiologist and founder of Step One Foods. She trained at Mayo Clinic and Johns Hopkins, and

More information

Statin use in persons with diabetes

Statin use in persons with diabetes Statin use in persons with diabetes 2018 American Diabetes Association recommendations for patients with diabetes ages 40 and older: * Presence of atherosclerotic cardiovascular disease (ASCVD) RECOMMENDED

More information

CRESTOR rosuvastatin calcium tablets

CRESTOR rosuvastatin calcium tablets PART III CONSUMER INFORMATION CRESTOR rosuvastatin calcium tablets This leaflet is part of a "Product Monograph" published when CRESTOR was approved for sale in Canada and is designed specifically for

More information

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe 26 April 2010 Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe PHARMAC is seeking feedback on the following proposals relating to the cholesterol lowering pharmaceuticals

More information

Atorvastatin route of administration

Atorvastatin route of administration Atorvastatin route of administration 8-3-2017 Atorvastatin Calcium. Atorvastatin Calcium Combinations; Routes.. Petrella G et al. Effects of simvastatin and atorvastatin administration on. 1-3-2017 Atorvastatin

More information

CARDIOVASCULAR DISEASE WHAT IS IT? WHAT IS THE ROLE OF CHOLESTEROL? HOW CAN WE REDUCE RISK?

CARDIOVASCULAR DISEASE WHAT IS IT? WHAT IS THE ROLE OF CHOLESTEROL? HOW CAN WE REDUCE RISK? 1 CARDIOVASCULAR DISEASE WHAT IS IT? WHAT IS THE ROLE OF CHOLESTEROL? HOW CAN WE REDUCE RISK? Perry J Weinstock, MD, F.A.C.C. Head, Division of Cardiovascular Disease Director of Clinical Cardiology Cooper

More information

BRITISH BIOMEDICAL BULLETIN

BRITISH BIOMEDICAL BULLETIN Journal Home Page www.bbbulletin.org BRITISH BIOMEDICAL BULLETIN Original Cost Analysis Study of HMG CoA Inhibitors Sirisha A.* Department of Pharmacology, Kamineni Institute of Medical Sciences, Narketpally,

More information

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/

More information

Crestor vs lipitor for women

Crestor vs lipitor for women Crestor vs lipitor for women If you've already found that your cholesterol levels are getting dangerously out of sync, you can. American Heart Association: High Risk Factors and Coronary Heart Disease.,

More information

A Review: Atherosclerosis & its treatment

A Review: Atherosclerosis & its treatment 73 Review Article A Review: Atherosclerosis & its treatment Yogesh K. Patil* Department of Pharmacology, Shree Mahavir Institute of Pharmacy, Nashik, Maharashtra, India *yogesh_kpatil85@yahoo.co.in ABSTRACT

More information

This document was created on 07 January 2005 and has been printed from

This document was created on 07 January 2005 and has been printed from 1 Spontaneous Adverse Event Reporting Information Introduction This document provides information regarding spontaneous adverse event reports received concerning patients taking rosuvastatin, which relates

More information

Medications for Type 2 Diabetes CDE Exam Preparation

Medications for Type 2 Diabetes CDE Exam Preparation Medications for Type 2 Diabetes CDE Exam Preparation Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Agenda Medication

More information

Atorvastatin 40 Mg Cost

Atorvastatin 40 Mg Cost Atorvastatin 40 Mg Cost lipitor 20 mg atorvastatin Free Coupons For Benicar Custa Xenical Manipulado atorvastatin 20 mg tablet price what is atorvastatin calcium tablets ip atorvastatin 40 mg tabletta

More information

7 KEYS. to Reduce Cholesterol. By Simeon Margolis, M.D., PH.D. & Roger S. Blumenthal, M.D. and the Editors of Johns Hopkins Health Alerts

7 KEYS. to Reduce Cholesterol. By Simeon Margolis, M.D., PH.D. & Roger S. Blumenthal, M.D. and the Editors of Johns Hopkins Health Alerts 7 KEYS to Reduce Cholesterol By Simeon Margolis, M.D., PH.D. & Roger S. Blumenthal, M.D. and the Editors of Johns Hopkins Health Alerts 7 KEYS 7 Keys to Reduce Cholesterol As many Americans are now aware,

More information

Primary Prevention Patients aged 85yrs and over

Primary Prevention Patients aged 85yrs and over Rotherham Guideline for the management of Non-Familial Hypercholesterolaemia Type 1 Diabetes Offer lifestyle advice Over 40yrs of age? Diabetic for more than 10 years? Established nephropathy? Other CVD

More information

9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management

9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH Introduction Background Management 2 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia to care coordinators/

More information